Skip to main content
Equibles
TRVI logo

TRVI · Trevi Therapeutics, Inc.

Track TRVI — free

Use TRVI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TRVI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$18.46 +0.31 (+1.71%) At close · Aug 14
Market Cap
$2.63B
Shares
142.48M

Trevi Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Trevi Therapeutics, Inc. (TRVI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-06
Trevi Therapeutics, Inc. Q2 FY2026 Earnings Call
Positive tone Clinical trial execution and enrollment Non-IPF ILD chronic cough program LAKE Phase 2B trial in RCC and SSRE
Diluted EPS
$-0.11
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Trevi Therapeutics, Inc. Q1 FY2026 Earnings Call
Confident tone Refractory chronic cough Phase IIb Competitive landscape and P2X3 Non-IPF-ILD chronic cough program
Diluted EPS
$-0.09
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Trevi Therapeutics, Inc. Q4 FY2025 Earnings Call
Confident tone FDA alignment and regulatory progress IPF-related chronic cough (Heduvio) Phase III program Non-IPF ILD chronic cough indication
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-11
Leerink Partners 2026 Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-13
Trevi Therapeutics, Inc. Q3 FY2025 Earnings Call
Confident tone Regulatory milestones and FDA interactions Refractory chronic cough (RCC) program Safety profile and tolerability of Nalbuphine ER
Diluted EPS
$-0.08
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Trevi Therapeutics, Inc. Q2 FY2025 Earnings Call
Confident tone IPF cough Phase III planning CORAL Phase IIb results Refractory chronic cough program
Diluted EPS
$-0.09
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-06-02
Trevi Therapeutics, Inc. Q1 FY2025 Earnings Call
Confident tone CORAL Phase 2b IPF Trial FDA Regulatory Engagement RIVER Phase 2a RCC Data
Diluted EPS
$-0.09
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-18
Trevi Therapeutics, Inc. Q4 FY2024 Earnings Call
Confident tone RCC (refractory chronic cough) opportunity Positive clinical readouts across Haduvio program IPF chronic cough lead indication and CORAL Phase 2b
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Trevi Therapeutics, Inc. Q3 FY2024 Earnings Call
Positive tone HAP study and DEA scheduling risk IPF chronic cough Phase 2b CORAL trial New CDO Jim Cassella
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Trevi Therapeutics, Inc. Q2 FY2024 Earnings Call
Positive tone RIVER Phase 2a RCC Trial CORAL Phase 2b IPF Chronic Cough Trial Supportive Studies (HAP and Respiratory Physiology)
Diluted EPS
$-0.12
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Trevi Therapeutics, Inc. Q1 FY2024 Earnings Call
Confident tone RIVER Phase IIa trial in refractory chronic cough CORAL Phase IIb trial in IPF chronic cough Human abuse potential study (HAP)
Diluted EPS
$-0.11
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-20
Trevi Therapeutics, Inc. Q4 FY2023 Earnings Call
Confident tone Phase 2b CORAL trial in IPF chronic cough Phase 2a RIVER trial in RCC Human Abuse Potential (HAP) study
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Trevi Therapeutics, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.08
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Trevi Therapeutics, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.07
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Trevi Therapeutics, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-0.06
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Trevi Therapeutics, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Trevi Therapeutics, Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-0.12
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Trevi Therapeutics, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-0.14
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Trevi Therapeutics, Inc. Q1 FY2022 Earnings Call
Diluted EPS
$-0.24
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-17
Trevi Therapeutics, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Trevi Therapeutics, Inc. Q3 FY2021 Earnings Call
Diluted EPS
$-0.34
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Trevi Therapeutics, Inc. Q2 FY2021 Earnings Call
Diluted EPS
$-0.49
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Trevi Therapeutics, Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-25
Trevi Therapeutics, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Trevi Therapeutics, Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
Trevi Therapeutics, Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 earnings calls
Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 213 filings 211 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)